Genocea Biosciences reported $0 in Market Capitalization this October of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agenus AGEN:US $ 0.52B 0.11B
Baxter International BAX:US $ 32.34B 6.68B
Bluebird Bio BLUE:US $ 0.3B 0.05B
Cytokinetics CYTK:US $ 3.36B 0.22B
Cytori Therapeutics CYTX:US $ 0.01B 0.01B
Genocea Biosciences GNCA:US $ 0.07B 0.01B
Glaxosmithkline GSK:US 109.29B 0.69B
Infinity Pharmaceuticals INFI:US $ 0.06B 0.05B
Merk MRK:US $ 230.55B 23.1B
Mirati Therapeutics MRTX:US $ 3.73B 0.84B
Moderna Inc MRNA:US $ 56.82B 12.6B
Novavax NVAX:US $ 4.02B 1.6B
Pfizer PFE:US $ 294.18B 1.79B
Prothena PRTA:US 1.27B 0.44B